The Food and Drug Administration’s (FDA) approval of the the drug Aduhelm (Aducanumab) for Alzheimer’s treatment though it has not been clinically proven to work and will cost $56,000 a year. In response to this approval, family members have made videos explaining why they don’t want Aduhelm for their loved ones. Watch their stories below.